Demand for Health Insurance

Handbook of Health Economics

Volumn 2, Issue , 2011, Pages 317-396

  McGuire, Thomas G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adverse selection; Demand for health; Demand for health care; Health care costs; HMOs; Insurance; Managed care; Moral hazard; Selective contracting

Indexed keywords

EID: 83255186902     PISSN: 15740064     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53592-4.00005-0     Document Type: Chapter

References (214)

1. Abaluck, J. & Gruber, J. (2011). Choice inconsistencies among the elderly: evidence from plan choice in Medicare Part D. American Economic Review: forthcoming.
2. Abraham J.M., Vogt W.B., Gaynor M.S. How do households choose their employer-based health insurance?. Inquiry 2006, 43(4):315-332.
3. Aitken M., Berndt E.R., Cutler D.M. Prescription drug spending trends in the United States: Looking beyond the turning point. Health Affairs (Millwood) 2009, 28(1):w151-w160.
4. Arrow K.J. Uncertainty and the welfare economics of medical care. American Economic Review 1963, 53(5):941-973.
5. Atherly A., Dowd B., Feldman R. The effect of benefits, premiums, and health risk on health plan choice in the Medicare program. Health Services Research 2004, 39(4:1):847-864.
6. Atherly A., Hebert P.L., Maciejewski M.L. An analysis of disenrollment from Medicare managed care plans by Medicare beneficiaries with diabetes. Medical Care 2005, 43(5):500-506.
7. Austin, D. A. & Hungerford, T. L. (2009). The market structure of the health insurance industry. Congressional Research Service R40834: November 17.
8. Baicker K., Goldman D. Patient cost-sharing and healthcare spending growth. Journal of Economic Perspectives 2011, 25(2):47-68.
9. Barry C.L., Frank R.G., McGuire T.G. The costs of mental health parity: Still an impediment?. Health Affairs (Millwood) 2006, 25(3):623-634.
10. Bauhoff, S., Hotchkiss, D. R., & Smith, O. (2010). The impact of medical insurance for the poor in Georgia: a regression discontinuity approach. Health Economics: forthcoming.
11. Berndt, E. R., McGuire, T. G., & Newhouse, J. P. (2011). A primer on the economics of pharmaceutical pricing in health insurance markets NBER Working Paper 16879.
12. Besley T.J. Optimal reimbursement health insurance and the theory of Ramsey taxation. Journal of Health Economics 1988, 7(4):321-336.
13. Bitran R., Munoz R. Global marketplace for private health insurance: Strength in numbers. Global marketplace for private health insurance: Strength in numbers 2010, The World Bank, Washington, DC. A.S. Preker, P. Zweifel, O. Schellekens (Eds.).
14. Bodenheimer T. California's beleaguered physician groups-will they survive?. New England Journal of Medicine 2000, 342(14):1064-1068.
15. Breyer, F., Bundorf, M. K., & Pauly, M. V. (2011). Health care spending risk, health insurance, and payment to health plans. Handbook of health economics, Elsevier.
16. Buchmueller T. Price and the health plan choices of retirees. Journal of Health Economics 2006, 25(1):81-101.
17. Bundorf, M. K. & Royalty, A. B. (2011). Price responsiveness in health plan choice. Working Paper.
18. Bundorf, M. K., Levin, J. D., & Mahoney, N. (2011). Pricing and welfare in health plan choice. American Economic Review: forthcoming.
19. Buntin M.B., Damberg C., Haviland A., Kapur K., Lurie N., McDevitt R., et al. Consumer-directed health care: Early evidence about effects on cost and quality. Health Affairs (Millwood) 2006, 25(6):w516-w530.
20. Buntin, M. B., Escarce, J. J., Kapur, K., Yegian, J. M., & Marquis, M. S. (2003). Trends and variability in individual insurance products in California. Health Affairs (Millwood), Suppl. Web Exclusives: W3-449-459.
21. California Public Employees' Retirement System (2004). CalPERS Health Plan Overview. Retrieved August 11, 2010, from https://www.calpers.ca.gov/index.jsp?bc=/about/benefits-overview/health-benefits.xml.
22. Capps C., Dranove D., Satterthwaite M. Competition and market power in option demand markets. RAND Journal of Economics 2003, 34(4):737-763.
23. Casalino, L. P. & Robinson, J. C. (1997). The evolution of medical groups and capitation in California. Henry J. Kaiser Foundation and California Health Care Foundation.
24. Chandra, A., Cutler, D., & Song, Z. (2011). Who ordered that? The economics of treatement choices in medical care. Handbook of health economics. Elsevier.
25. Chandra A., Gruber J., McKnight R. Patient cost-sharing, hospitalization offsets, and the design of hospital insurance for the elderly. American Economic Review 2010, 100(1):193-213.
26. Cheng T., Reinhardt U.E. Shepherding major health system reforms: A conversation with German Health Minister Ulla Schmidt. Health Affairs 2008, 27(3):w204-w213.
27. Chernew M.E., Fendrick A.M. Value and increased cost sharing in the American health care system. Health Services Research 2008, 43(2):451-457.
28. Chernew M.E., Encinosa W.E., Hirth R.A. Optimal health insurance: The case of observable, severe illness. Journal of Health Economics 2000, 19:585-609.
29. Chernew M.E., Gibson T.B., Yu-Isenberg K., Sokol M.C., Rosen A.B., Fendrick A.M. Effects of increased patient cost sharing on socioeconomic disparities in health care. Journal of General Internal Medicine 2008, 23(8):1131-1136.
30. Chernew, M. E., Gowrisankaran, G., & Scanlon, D. P. (2008b). Learning and the value of information: Evidence from health plan report cards. NBER Working Paper 8589.
31. Chernew M.E., Juster I.A., Shah M., Wegh A., Rosenberg S., Rosen A.B., et al. Evidence that value-based insurance can be effective. Health Affairs (Millwood) 2010, 29(3):530-536.
32. Chernew M.E., Rosen A.B., Fendrick A.M. Value-based insurance design. Health Affairs (Millwood) 2007, 26(2):w195-w203.
33. Chernew M.E., Shah M.R., Wegh A., Rosenberg S.N., Juster I.A., Rosen A.B., et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Affairs (Millwood) 2008, 27(1):103-112.
34. Choudhry, N., & others (2010a).
35. Choudhry N., Rosenthal M.B., Milstein A. Assessing the evidence for value-based insurance design. Health Affairs (Millwood) 2010, 29(11):1988-1994.
36. Christianson J.B., Conrad D. Provider payment and incentives. The Oxford handbook of health economics 2011, 624-648. Oxford University Press, Oxford. S.A. Glied, P.C. Smith (Eds.).
37. Commonwealth Health Insurance Connector Authority (2010a). Connector summary report. Commonwealth Health Insurance Connector Authority Boston, MA.
38. Commonwealth Health Insurance Connector Authority (2010b). Commonwealth care plans by region, from http://www.mahealthconnector.org/.
39. Congressional Budget Office (CBO) Key issues in analyzing major health insurance proposals, December 2008.
40. Cook K., Dranove D., Sfekas A. Does major illness cause financial catastrophe?. Health Services Research 2010, 45(2):418-436.
41. Cox E., Klukarni A., Henderson R. Impact of patient and plan design factors on switching to preferred statin therapy. The Annals of Pharmacotherapy 2007, 41(1):1946-1953.
42. Cutler D.M., Reber S.J. Paying for health insurance: The tradeoff between competition and adverse selection. Quarterly Journal of Economics 1998, 113(2):433-466.
43. Cutler D.M., Zeckhauser R. The anatomy of health insurance. Handbook of health economics 2000, North Holland, Elsevier, Amsterdam. A.J. Culyer, J.P. Newhouse (Eds.).
44. Cutler D.M., Lincoln B., Zeckhauser R. Selection stories: Understanding movement across health plans. Journal of Health Economics 2010, 29(6):821-838.
45. Cutler D.M., McClellan M., Newhouse J.P. How does managed care do it?. RAND Journal of Economics 2000, 31(3):526-548.
46. Dafny L. Are health insurance markets competitive?. American Economic Review 2010, 100(4):1399-1492.
47. Dafny, L., Ho, K., & Varela, M. (2010). Let them have choice; gains from shifting away from employer-sponsored health insurance and toward an individual exchange. NBER Working Paper 16687.
48. Damrongplasit K., Melnick G.A. Early results from Thailand's 30 Baht Health Reform: Something to smile about. Health Affairs (Millwood) 2009, 28(3):w457-w466.
49. Danzon P.M., Pauly M.V. Health insurance and the growth in pharmaceutical expenditures. Journal of Law and Economics 2002, 45(1):587-613.
50. De Meza D. Health insurance and the demand for medical care. Journal of Health Economics 1983, 2:47-54.
51. Diamond P. Organizing the health insurance market. Econometrics 1992, 60(6):1233-1254.
52. Dowd B.E., Feldman R. Premium elasticities of health plan choice. Inquiry 1994-1995, 31(4):438-444.
53. Dowd B.E., Feldman R., Coulam R. The effect of health plan characteristics on Medicare+ choice enrollment. Health Services Research 2003, 38(1 Pt 1):113-135.
54. Dranove, D. (2011). Health care markets, regulators, and certifiers. Handbook of health economics. Elsevier.
55. Dranove D., Millenson M.L. Medical bankruptcy: Myth versus fact. Health Affairs (Millwood) 2006, 25(2):w74-w83.
56. Dranove D., Shanley M., White W. Price and concentration in hospital markets: The switch from patient to payer-driven competition. Journal of Law and Economics 1993, 36:179-204.
57. Duggan M. Do new prescription drugs pay for themselves? The case of second-generation antipsychotics. Journal of Health Economics 2005, 24(1):1-31.
58. Duggan M., Scott Morton F. The effect of Medicare Part D on pharmaceutical prices and utilization. American Economic Review 2010, 100(1):590-607.
59. Duggan M., Healy P., Morton F.S. Providing prescription drug coverage to the elderly: America's experiment with Medicare Part D. Journal of Economic Perspectives 2008, 22(4):69-92.
60. Einav L., Finkelstein A. Selection in insurance markets: Theory and empirics in pictures. Journal of Economic Perspectives 2011, 25(1):115-138.
61. Einav L., Finkelstein A., Cullen M.R. Estimating welfare in insurance markets using variation in prices. Quarterly Journal of Economics 2010, 125(3):877-921.
62. Elbel B., Schlesinger M. How much choice? Nonlinear relationships between the number of plan options and the behavior of Medicare beneficiaries 2010, Working Paper. Yale University, Working Paper.
63. Ellis R.P., Manning W.G. Optimal health insurance for prevention and treatment. Journal of Health Economics 2007, 26(6):1128-1150.
64. Ellis R.P., McGuire T.G. Provider behavior under prospective reimbursement. Cost sharing and supply. Journal of Health Economics 1986, 5(2):129-151.
65. Ellis R.P., McGuire T.G. Setting capitation payments in markets for health services. Health Care Financing Review 1987, 8(4):55-64.
66. Ellis R.P., McGuire T.G. Optimal payment systems for health services. Journal of Health Economics 1990, 9:375-396.
67. Ellis R.P., McGuire T.G. Supply-side and demand-side cost sharing in health care. Journal of Economic Perspectives 1993, 7(4):135-151.
68. Ellis R.P., McGuire T.G. Predictability and predictiveness in health care spending. Journal of Health Economics 2007, 26(1):25-48.
69. Ellison S.F., Cockburn I., Griliches Z., Hausman J. Characteristics of demand for pharmaceutical products: An examination of four cephalosporins. RAND Journal of Economics 1997, 28(3):426-446.
70. Enthoven A.C. Rx for health care economics: Competition, not rigid NHI. Hospital Progress 1978, 59(10):44-51.
71. Enthoven A.C., Kronick R. A consumer-choice health plan for the 1990s. Universal health insurance in a system designed to promote quality and economy (2). New England Journal of Medicine 1989, 320(2):94-101.
72. Feldman R., Parente S.T., Christianson J.B. Consumer-directed health plans: New evidence on spending and utilization. Inquiry 2007, 44(1):26-40.
73. Feldman R.D., Dowd B.E. Simulation of a health insurance market with adverse selection. Operations Research 1982, 30(6):1027-1042.
74. Fendrick A.M., Chernew M.E. Value-based insurance design: Aligning incentives to bridge the divide between quality improvement and cost containment. American Journal of Managed Care 2006, December 12(Spec no.):SP5-SP10.
75. Fendrick A.M., Smith D.G., Chernew M.E. Applying value-based insurance design to low-value health services. Health Affairs (Millwood) 2010, 29(11):2017-2021.
76. Finkelstein, A. N., Luttmer, E., & Notowidigdo, M. J. (2009). What good is wealth without health? The effect of health on the marginal utility of consumption. NBER Working Paper No. 14089.
77. Florence C.S., Thorpe K.E. How does the employer contribution for the federal employees health benefits program influence plan selection?. Health Affairs (Millwood) 2003, 22(2):211-218.
78. Foote S.M., Jones S.B. Consumer-choice markets: Lessons from FEHBP mental health coverage. Health Affairs (Millwood) 1999, 18(5):125-130.
79. Frank R. Behavior economics and health economics. Behavioral economics and its applications 2007, Princeton University Press. P. Diamond, H. Vartiainen (Eds.).
80. Frank, R., & Lamiraud, K. (2009). Choice, price competition and complexity in markets for health insurance. Journal of Economic Behavior and Organization: forthcoming.
81. Frank R.G., McGuire T.G. Economics and mental health. Handbook of health economics 2000, Elsevier, North Holland. A.J. Culyer, J.P. Newhouse (Eds.).
82. Frank R.G., Glazer J., McGuire T.G. Measuring adverse selection in managed health care. Journal of Health Economics 2000, 19(6):829-854.
83. Friedson E. Prepaid group practice and the new demanding patient. Milbank Memorial Fund Quarterly 1973, 51(4):473-488.
84. Fronstin P. Sources of health insurance and characteristics of the uninsured: Analysis of the March 2009 Current Population Survey. EBRI Issue Brief 2009, (334):1-35.
85. Gabel J., Claxton G., Gil I., Pickreign J., Whitmore H., Finder B., et al. Health benefits in 2005: Premium increases slow down, coverage continues to erode. Health Affairs (Millwood) 2005, 24(5):1273-1280.
86. Gaynor M., Haas-Wilson D. Change, consolidation, and competition in health care markets. Journal of Economic Perspectives 1999, 13(1):141-164.
87. Gaynor M., Li J., Vogt W.B. Substitution, spending offsets, and prescription drug benefit design. Forum for Health Economics and Policy 2007, 10(2):1-31.
88. Gibson T.B., Mark T.L., McGuigan K.A., Axelsen K., Wang S. The effects of prescription drug copayments on statin adherence. American Journal of Management Care 2006, 12(9):509-517.
89. Gibson T.B., Ozminkowsk R.J., Goetzel R.Z. The effects of prescription drug cost sharing: A review of the evidence. American Journal of Management Care 2005, 11(11):730-740.
90. Gilman B.H., Kautter J. Consumer response to dual incentives under multitiered prescription drug formularies. American Journal of Management Care 2007, 13(6 Pt 2):353-359.
91. Gilman B.H., Kautter J. Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries. Health Services Research 2008, 43(2):478-495.
92. Glazer J., McGuire T.G. Optimal risk adjustment of health insurance premiums: An application to managed care. American Economic Review 2000, 90(4):1055-1071.
93. Glazer J., McGuire T.G. Private employers don't need formal risk adjustment. Inquiry 2001, 38(3):260-269.
94. Glazer J., McGuire T.G. Setting health plan premiums to ensure efficient quality in health care: Minimum variance optimal risk adjustment. Journal of Public Economics 2002, 84(2):153-173.
95. Glazer, J., & McGuire, T. G. (2010). What to count as "offset effects" in health insurance design. Unpublished September 14, 2010.
96. Glazer, J., & McGuire, T. G. (2011). Gold and silver health plans: Accommodating demand heterogeneity in managed competition. Journal of Health Economics. Available online: DOI: 10.1016/j.jhealeco.2011.1005.1018.
97. Goldman D.P., Philipson T.J. Integrated insurance design in the presence of multiple medical technologies. The American Economic Review 2007, 97(2):427-432.
98. Goldman D.P., Jena A.B., Philipson T., Sun E. Drug licenses: A new model for pharmaceutical pricing. Health Affairs (Millwood) 2008, 27(1):122-129.
99. Goldman D.P., Joyce G.F., Zheng Y. Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. JAMA 2007, 298(1):61-69.
100. Goldstein G.S., Pauly M.V. Group health insurance as a local public good. The role of health insurance in the health services sector 1976, National Bureau for Economic Research, New York. R.N. Rosett (Ed.).
101. Gruber, J. (2006). The role of consumer copayments for health care: lessons from the RAND Health Insurance Experiment and beyond. Kaiser Family Foundation, October.
102. Gruber J. Covering the uninsured in the United States. Journal of Economic Literature 2008, 46(3):571-606.
103. Gruber J., Levy H. The evolution of medical spending risk. Journal of Economic Perspectives 2009, 23(4):25-48.
104. Gruber J., Rodriguez D. How much uncompensated care do doctors provide?. Journal of Health Economics 2007, 26(6):1151-1169.
105. Gruber J., Washington E. Subsidies to employee health insurance premiums and the health insurance market. Journal of Health Economics 2005, 24(2):253-276.
106. Handel B. Adverse selection and switching costs in health insurance markets: When nudging hurts. Unpublished Working Paper 2010.
107. Herring B. The effect of the availability of charity care to the uninsured on the demand for private health insurance. Journal of Health Economics 2005, 24(2):225-252.
108. Himmelstein, D. U., Warren, E., Thorne, D., & Woolhandler, S. (2005). Illness and injury as contributors to bankruptcy. Health Affairs (Millwood) Suppl. Web Exclusives: W5-63-W65-73.
109. Hsiao W.C., Shaw R.P., Fraker A. Social health insurance for developing nations 2007, The World Bank, Washington, DC.
110. Hsu J., Price M., Huang J., Brand R., Fung V., Hui R., et al. Unintended consequences of caps on Medicare drug benefits. New England Journal of Medicine 2006, 354(22):2349-2359.
111. Huskamp, H. A., et al. (2009).
112. Huskamp H.A., Deverka P.A., Epstein A.M., Epstein R.S., McGuigan K.A., Frank R.G. The effect of incentive-based formularies on prescription-drug utilization and spending. New England Journal of Medicine 2003, 349(23):2224-2232.
113. Huskamp H.A., Deverka P.A., Epstein A.M., Epstein R.S., McGuigan K.A., Muriel A.C., et al. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Archives of General Psychiatry 2005, 62(4):435-441.
114. Jack W., Sheiner L. Welfare improving health subsidies. American Economic Review 1997, 87(2):206-221.
115. Jin G.Z., Sorensen A.T. Information and consumer choice: The value of publicized health plan ratings. Journal of Health Economics 2006, 25(2):248-275.
116. Joyce G.F., Goldman D.P., Vogt W.B., Sun E., Jena A.B. Medicare Part D after 2 years. American Journal of Management Care 2009, 15(8):536-544.
117. Kaiser Family Foundation and Health Services & Educational Trust (2009). Employer Health Benefits: 2009 Annual Survey, from http://ehbs.kff.org/pdf/2009/7936.pdf.
118. Kaiser Family Foundation and Health Services & Educational Trust (2010). Employer Health Benefits: 2010 Annual Survey, from http://ehbs.kff.org/pdf/2010/8085.pdf.
119. Keeler E.B., Rolph J.E. The demand for episodes of treatment in the Health Insurance Experiment. Journal of Health Economics 1988, 7(4):337-367.
120. Keenan P., Cutler D.M., Chernew M.E. The "graying" of group health insurance. Health Affairs (Millwood) 2006, 25(6):1497-1506.
121. Kingsdale J., Bertko J. Insurance exchanges under health reform: Six design issues for the states. Health Affairs (Millwood) 2010, 29(6):1158-1163.
122. Kremer, M. & Glennerster, R. (2011). Improving health in developing countries: Evidence from randomized evaluations. Handbook of health economics. Elsevier.
123. Landon B.E., Rosenthal M.B., Normand S.L., Spettell C., Lessler A., Underwood H.R., et al. Incentive formularies and changes in prescription drug spending. American Journal of Management Care 2007, 13(6 Pt 2):360-369.
124. Leibman, J. & Zeckhauser, R. (2008). Simple humans, complex insurance, subtle subsidies. NBER Working Paper 14330.
125. Lichtenberg F.R., Sun S.X. The impact of Medicare Part D on prescription drug use by the elderly. Health Affairs (Millwood) 2007, 26(6):1735-1744.
126. Lo Sasso A.T., Shah M., Frogner B.K. Health savings accounts and health care spending. Health Services Research 2010, 45(4):1041-1060.
127. Lohr K.N., Brook R.H., Kamber C.J. Effect of cost sharing on use of medically effective and less effective care. Medical Care 1986, 24(9):S31-S38.
128. Lu C., Frank R., McGuire T.G. Demand response of mental health services to cost sharing under managed care. Journal of Mental Health Policy and Economics 2008, 11(3):113-126.
129. Lu C., Frank R.G., McGuire T.G. Demand response under managed health care. Contemporary Economic Policy 2009, 27(1):1-15.
130. Lungen M., Stollenwerk B., Messner P., Lauterbach K.W., Gerber A. Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany. International Journal of Equity Health 2008, 7:1.
131. Ma C.A., McGuire T.G. Costs and incentives in a behavioral health carve-out. Health Affairs (Millwood) 1998, 17(2):53-69.
132. Ma C.A., McGuire T.G. Network incentives in managed health care. Journal of Economics & Management Strategy 2002, 11(1):1-35.
133. Ma C.A., Riordan M.H. Health insurance, moral hazard, and managed care. Journal of Economics & Management Strategy 2002, 11:81-107.
134. Maciejewski M.L., Farley J.F., Parker J., Wansink D. Copayment reductions generate greater medication adherence in targeted patients. Health Affairs (Millwood) 2010, 29(11):2002-2008.
135. Manning, W. G., & Marquis, M. S. (1989). Health insurance: Trade-off between risk sharing and moral hazard. Pub. No. R-3729-NCHSR.
136. Manning W.G., Marquis M.S. Health insurance: The Tradeoff between risk pooling and moral hazard. Journal of Health Economics 1996, 15(5):609-639.
137. Manning W.G., Newhouse J.P., Duan N., Keeler E.B., Leibowitz A. Health insurance and the demand for medical care: Evidence from a randomized experiment. American Economic Review 1987, 77(3):251-277.
138. Marquis M.S., Long S.H. Worker demand for health insurance in the non-group market. Journal of Health Economics 1995, 14(1):47-63.
139. McFadden D. Free markets and fettered consumers. American Economic Review 2006, 96(1):5-29.
140. McGuire T.G. Price and membership in a prepaid group medical practice. Medical Care 1981, 18(2):172-183.
141. McGuire T.G. Physician agency. Handbook of health economics 2000, Vol. 1:461-536. Elsevier.
142. McGuire T.G., Bauhoff S. A decade of choice tracking the German national experience with consumer choice of sickness fund. Auf der Suche nach der besseren Lösung 2007, 145-160. Baden-Baden Nomos Ver Lagsgesellschaft. P. Oberender, C. Staub (Eds.).
143. McGuire T.G., Bauhoff S. Adoption of a cost-saving innovation: Germany, UK and simvastatin. England and Germany in Europe-What lessons can we learn from each other? 2011, 11-26. Nomos Verlag, Baden-Baden, Germany. N. Klusen, F. Verheyen, C. Wagner (Eds.).
144. McGuire T.G., Sinaiko A.D. Regulating a health insurance exchange: Implications for individuals with mental illness. Psychiatric Services 2010, 61(11):1074-1080.
145. McGuire T.G., Newhouse J.P., Sinaiko A. An economic history of Medicare Part C. Milbank Quarterly 2011, 89(2):289-332.
146. McWilliams, J. M., Afendulis, C., Landon, B. E., & McGuire, T. G. (2011). Cognitive functioning and choice between traditional Medicare and Medicare Advantage. Health Affairs: forthcoming.
147. Melnick G.A., Zwanziger J. Hospital behavior under competition and cost-containment policies. the California experience, 1980 to 1985. JAMA 1988, 260(18):2669-2675.
148. Melnick G.A., Zwanziger J., Bamezai A., Pattison R. The effects of market structure and bargaining position on hospital prices. Journal of Health Economics 1992, 11(3):217-233.
149. Miller, G., Pinto, D. M., & Vera-Hernández, M. (2009). High-powered incentives in developing country health insurance: Evidence from Colombia's Régimen Subsidiado. National Bureau of Economic Research Working Paper Series No. 15456.
150. Miller N.H. Pricing health benefits: A cost-minimization approach. Journal of Health Economics 2005, 24(5):931-949.
151. Morrisey M.A. Health insurance 2008, Health Administration Press.
152. Newhouse J.P. Free-for-all: Health insurance, medical costs, and health outcomes: The results of the health insurance experiment 1993, Harvard University Press, Cambridge, MA.
153. Newhouse J.P. Reconsidering the moral hazard-risk avoidance tradeoff. Journal of Health Economics 2006, 25(5):1005-1014.
154. Nyman J. The economics of moral hazard revisited. Journal of Health Economics 1999, 18(6):811-823.
155. Nyman J. The value of health insurance: The access motive. Journal of Health Economics 1999, 18(2):141-152.
156. Nyman J.A. The theory of demand for health insurance 2003, Stanford University Press.
157. Nyman J.A. Health insurance theory: The case of the missing welfare gain. European Journal of Health Economics 2008, 9:369-380.
158. Olmstead T., Zeckhauser R. The menu-setting problem and subsidized prices: Drug formulary illustration. Journal of Health Economics 1999, 18(5):523-550.
159. Organization for Economic Cooperation and Development (OECD) (2004). Private health insurance in OECD countries, from http://www.oecd.org/dataoecd/42/6/33820355.pdf.
160. Padgett D.K., Patrick C., Burns B.J., Schlesinger H.J., Cohen J. The effect of insurance benefit changes on use of child and adolescent outpatient mental health services. Medical Care 1993, 31(2):96-110.
161. Parente S.T., Feldman R., Christianson J.B. Employee choice of consumer-driven health insurance in a multiplan, multiproduct setting. Health Services Research 2004, 39(4 Pt 2):1091-1112.
162. Pauly M. The economics of moral hazard: Comment. American Economic Review 1968, 58:531-536.
163. Pauly M., Blavin F. Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignorance. Journal of Health Economics 2008, 27(6):1407-1418.
164. Pauly M.V., Held P.J. Benign moral hazard and the cost-effectiveness analysis of insurance coverage. Journal of Health Economics 1990, 9(4):447-461.
165. Pauly M.V., Ramsey S.D. Would you like suspenders to go with that belt? An analysis of optimal combinations of cost sharing and managed care. Journal of Health Economics 1999, 18(4):443-458.
166. Pauly M.V., Blavin F.E., Meghan S. How private, voluntary health insurance can work in developing countries. Health Affairs (Millwood) 2009, 28(6):1778-1787.
167. Phelps, C. E. (1973). The demand for health insurance: A theoretical and empirical investigation. Report R-1054-OEO.
168. Phelps C.E. The demand for reimbursement insurance. The role of health insurance in the health services sector 1976, National Bureau for Economic Research, New York. R. Rosett (Ed.).
169. Phelps C.E. Health economics 2010, Addison-Wesley. 4th ed.
170. Pigou A.C. Economics of welfare 1920, Macmillian and Co, London, England.
171. Pizer S.D., Frakt A.B., Feldman R. Payment policy and inefficient benefits in the Medicare+Choice program. International Journal of Health Care Finance and Economics 2003, 3(2):79-93.
172. Relman A.S. Could physicians take the lead in health reform?. Journal of the American Medical Association 2010, 304(24):2740-2741.
173. Rice T. An alternative framework for evaluating, welfare losses in the health care market. Journal of Health Economics 1992, 11(1):88-92.
174. Rice T., Matsuoka K.Y. The impact of cost-sharing on appropriate utilization and health status: A review of the literature on seniors. Medical Care Research and Review 2004, 61(4):415-452.
175. Ridley, D. (2009). Payments, promotion, and the purple pill. The Fuqua School of Business, Duke University: Working Paper.
176. Robinson J.C. Health care purchasing and market changes in California. Health Affairs (Millwood) 1995, 14(4):117-130.
177. Robinson J.C. Decline in hospital utilization and cost inflation under managed care in California. JAMA 1996, 276(13):1060-1064.
178. Robinson J.C. Applying value-based insurance design to high-cost health services. Health Affairs (Millwood) 2010, 29(11):2009-2016.
179. Robinson, J. C. & Casalino, L. P. (2001). Reevaluation of capitation contracting in New York and California. Health Affairs (Millwood) Suppl. Web Exclusives: W11-W19.
180. Rosenthal M.B., Li Z., Milstein A. Do patients continue to see physicians who are removed from a PPO network?. American Journal of Management Care 2009, 15(10):713-719.
181. Rothschild M., Stiglitz J. Equilibrium in competitive insurance markets: An essay on the economics of imperfect information. Quarterly Journal of Economics 1976, 90(4):629-649.
182. Royalty A.B., Soloman N. Health plan choice: Price elasticities in a managed care setting. Journal of Human Resources 1989, 34:1-41.
183. Rysman M. The economics of two-sided markets. Journal of Economic Perspectives 2009, 23(3):125-143.
184. Samuelson W., Zeckhauser R. Status quo bias in decisionmaking. Journal of Risk and Uncertainty 1988, 1:7-59.
185. Sass H.-M. The new triad: Responsibility, solidarity, and subsidiarity. Journal of Medicine and Philosophy 1995, 20:587-594.
186. Scanlon D.P., Lindrooth R., Christianson J.B. Steering patients to safer hospitals? The effect of a tiered hospital network on hospital admission. Health Services Research 2008, 43(5 pt II):1849-1868.
187. Scott Morton, F. & Kyle, M. (2011). Markets for pharmaceutical products. Handbook of health economics. Elsevier.
188. Selby J.V., Fireman B.H., Swain B.E. Effect of a copayment on use of the emergency department in a health maintenance organization. New England Journal of Medicine 1996, 334(10):635-641.
189. Shang B., Goldman D.P. Prescription drug coverage and elderly medicare spending. NBER Working Paper 13358 2007.
190. Simon K. Adverse selection in health insurance markets: Evidence from state small-group health insurance reforms. Journal of Public Economics 2005, 89(9-10):1865-1877.
191. Sinaiko A.D., Hirth R.A. Consumers, health insurance and dominated choices. Journal of Health Economics 2011, 30(2):450-457.
192. Song, Z., Safran, D., Landon, B. E., He, Y., Ellis, R. P., Mechanic, R., et al. (2011). Effect of the alternative quality contract on health care spending and quality. New England Journal of Medicine: forthcoming.
193. Squires, D., & others (2010). International profiles of health care systems. The Commonwealth Fund. Retrieved April 4, 2010, from http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2010/Jun/1417_Squires_Intl_Profiles_622.pdf.
194. Starr P. The social transformation of American medicine 1983, Basic Books.
195. Stock S., Redaelli M., Lauterbach K.W. The influence of the labor market on German health care reforms. Health Affairs (Millwood) 2006, 25(4):1143-1152.
196. Stone D.A. The struggle for the soul of health insurance. Journal of Health Politics, Policy and Law 1993, 18(2):287-317.
197. Strombom B.A., Buchmueller T.C., Feldstein P.J. Switching costs, price sensitivity and health plan choice. Journal of Health Economics 2002, 21(1):89-116.
198. Swartz, K. (2010). Cost-sharing: Effects on spending and outcomes; the Synthesis Project Issue 20. Robert Wood Johnson Foundation, from http://www.rwjf.org/files/research/121710.policysynthesis.costsharing.rpt.pdf.
199. Thomson, S., Foubister, T., & Mossialos, E. (2009). Financing health care in the European Union Challenges and policy responses. European Observatory on Health Systems and Policies. Retrieved April 4, 2010, from http://www.euro.who.int/__data/assets/pdf_file/0009/98307/E92469.pdf.
200. Town R., Vistnes G. Hospital competition in HMO networks. Journal of Health Economics 2001, 20(5):733-753.
201. US Government Accountability Office (GAO) (2003). Private health insurance: Federal and state requirement affecting coverage by small businesses.
202. US Government Accountability Office (GAO) (2009). Private health insurance: Research on competition in the insurance industry. GAO-09-8645, from http://www.gao.gov/new.items/d09864r.pdf.
203. US Office of Personnel Management (2004). Health care reform. Retrieved August 11, 2010, from http://www.opm.gov/insure/.
204. Van de Ven W.P.M.M., Ellis R.P. Risk adjustment in competitive health plan markets. Handbook of health economics 2000, Elsevier, Amsterdam. A.J. Culyer, J.P. Newhouse (Eds.).
205. Van de Ven W.P., Beck K., Van de Voorde C., Wasem J., Zmora I. Risk adjustment and risk selection in Europe: 6 years later. Health Policy 2007, 83(2-3):162-179.
206. Waters H.R., Hobart J., Forrest C.B., Siemens K.K., Pittman P.M., Murthy A., et al. Health insurance coverage in Central and Eastern Europe: Trends and challenges. Health Affairs (Millwood) 2008, 27(2):478-486.
207. World Health Organization (WHO) (2010). World Health Statistics. Retrieved July 7, 2010, from http://www.who.int/whosis/whostat/2010/en/index.html.
208. Wu V.Y. Managed care's price bargaining with hospitals. Journal of Health Economics 2009, 28(2):350-360.
209. Xu K., Evans D.B., Carrin G., Aguilar-Rivera A.M., Musgrove P., Evans T. Protecting households from catastrophic health spending. Health Affairs (Millwood) 2007, 26(4):972-983.
210. Zeckhauser R. Medical insurance: A case study of the tradeoff between risk spreading and appropriate incentives. Journal of Economic Theory 1970, 2:10-26.
211. Zhang Y. Cost-saving effects of olanzapine as long-term treatment for bipolar disorder. Journal of Mental Health Policy and Economics 2008, 11(3):135-146.
212. Zhang Y., Soumerai S.B. Do newer prescription drugs pay for themselves? A reassessment of the evidence. Health Affairs (Millwood) 2007, 26(3):880-886.
213. Zhang Y., Donohue J.M., Lave J.R., O'Donnell G., Newhouse J.P. The effect of Medicare Part D on drug and medical spending. New England Journal of Medicine 2009, 361(1):52-61.
214. Zweifel P., Breyer F., Kiffman M. Health economics 2009, Oxford University Press. 2nd ed.